Generalized Morphea with Vascular Involvement: A Case Report and Disaccharide Analysis of the Skin Glycosaminoglycans

Acta Dermato-Venereologica

Volumn 76, Issue 2, 1996, Pages 141-143

  Akimoto, S ^a   Ishikawa, O ^a   Yokoyama, Y ^a   Amano, H ^a   Miyachi, Y ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Interstitial change; Systemic sclerosis; Vascular change

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN;

AGED; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; MALE; MORPHEA; PRIORITY JOURNAL; SCLERODERMA; VASCULAR DISEASE;

AGED; BIOPSY, NEEDLE; GLYCOSAMINOGLYCANS; HUMANS; MALE; SCLERODERMA, LOCALIZED; SKIN; VASCULITIS;

EID: 0029864770     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schachter RK. Localized scleroderma. Curr Opin Rheumatol 1989; 1: 505-511.
2. Christianson HB, Dorsey CS, O'Leary PA. Localized scleroderma. Arch Dermatol 1956; 74: 629-639.
3. Fleischmajer R, Nedwich A. Generalized morphea. Arch Dermatol 1972; 106: 509-514.
4. Akimoto S, Hayashi H, Ishikawa H. Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis. Br J Dermatol 1992; 126: 29-34.
5. Higuchi T, Ohnishi K, Hayashi H, Ishikawa O, Miyachi Y. Changes in skin disaccharide components correlate with the severity of sclerotic skin in systemic sclerosis. Acta Derm Venereol (Stockh) 1994; 74: 179-182.
6. Tajima S, Nishikawa T, Hatano H, Nagai Y. Distribution of glycosaminoglycans in dermal connective tissue from scleroderma patients. J Dermatol 1982; 9: 405-408.
7. Honda S, Akao E, Suzuki S, Okuda M, Kakehi K, Nakamura J. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl-5-pyrazolone derivatives. Anal Biochem 1989; 180: 351-357.
8. Kahaleh MB, Sherer GK, LeRoy EC. Endothelial injury in scleroderma. J Exp Med 1979; 149: 1326-1335.
9. Prescott RJ, Freemont AJ, Jones CJP, Hoyland J, Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992; 166: 255-263.
10. Kahaleh MB. The role of vascular endothelium in fibroblast activation and tissue fibrosis, particularly in scleroderma (systemic sclerosis) and pachydermoperiostosis (primary hypertrophic osteoarthropathy). Clin Exp Rheumatol 1992; 10: 51-56.
11. Hoyland JA, Newson L, Jayson MIV, Freemont AJ. The vascular basement membrane in systemic sclerosis skin: heterogeneity of type IV collagen. Br J Dermatol 1993; 129: 384-388.
12. Blann AD, Illingworth K, Jayson MIV. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993; 20: 1325-1330.
13. Belch JJF. Raynaud's phenomenon: its relevance to scleroderma. Ann Rheum Dis 1991; 50: 839-845.
14. Norton WL, Nardo JM. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970; 73: 317-324.
15. Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975; 4: 351-368.
16. Ishikawa H, Mon S. Ein Beitrag zum histologischen Unterschied zwischen progressiver und circumscripter Sklerodermie. Hautarzt 1972; 23: 404-409.
17. Kobayasi T, Serup J. Vascular changes in morphea. Acta Derm Venereol (Stockh) 1985; 65: 116-120.
18. Maeda H, Ishikawa H, Ohta S. Circumscribed myxoedematosus as a sign of faulty formation of the proteoglycan macromolecule. Br J Dermatol 1981; 105: 239-245.
19. Vogel KG, Paulsson M, Heinegård D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984; 223: 587-597.
20. Birdi N, Lexer RM, Thorner P, Fritzler MJ, Silverman ED. Localized scleroderma progressing to systemic disease. Arthritis Rheum 1993; 36: 410-415.
21. Soma Y, Tamaki T, Kikuchi K, Abe M, Igarashi A, Takehara K, et al. Coexistence of morphea and systemic sclerosis. Dermatology 1993; 186: 103-105.
22. Czirják L, Pócs E, Szegedi G. Localized scleroderma after exposure to organic solvents. Dermatology 1994; 189: 399-401.
23. Haustein UF, Ziegler V. Environmentally induced systemic sclerosis-like disorders. Int J Dermatol 1985; 24: 147-151.